Prognostic Significance of Estimated Glomerular Filtration Rate and Cystatin C in Patients with Acute Intracerebral Hemorrhage

Cerebrovascular Diseases

Volumn 42, Issue 5-6, 2016, Pages 455-463

  You, Shoujiang ^a   Shi, Luyao ^a   Zhong, Chongke ^b   Xu, Jiaping ^a   Han, Qiao ^c   Zhang, Xia ^a   Liu, Huihui ^a   Zhang, Yanlin ^a   Shi, Jijun ^a   Huang, Zhichao ^a   Cao, Yongjun ^a,d   Liu, Chunfeng ^a,d  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c Suzhou Hospital of Traditional Chinese Medicine   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

3 Month disability; Cystatin C; Estimated glomerular filtration rate; Intracerebral hemorrhage; Mortality

Indexed keywords

CREATININE; CYSTATIN C; GLUCOSE; BIOLOGICAL MARKER; CST3 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ASSESSMENT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; SCORING SYSTEM; ACUTE DISEASE; AGED; BLOOD; CHI SQUARE DISTRIBUTION; CHRONIC KIDNEY FAILURE; CONVALESCENCE; DISABILITY; KAPLAN MEIER METHOD; KIDNEY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; CYSTATIN C; DISABILITY EVALUATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84991721384     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000448340     Document Type: Article

References (25)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355-369.
2. Lovelock CE, Molyneux AJ, Rothwell PM: Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007; 6: 487-493.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
4. Shlipak MG, Sarnak MJ, Katz R, et al: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
5. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V: Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010; 341:c4986.
6. Putaala J, Haapaniemi E, Gordin D, et al: Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke. Stroke 2011; 42: 2459-2464.
7. Tsagalis G, Akrivos T, Alevizaki M, et al: Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant 2009; 24: 194-200.
8. Rhoney DH, Parker D Jr, Millis SR, Whittaker P: Kidney dysfunction at the time of intracerebral hemorrhage is associated with increased in-hospital mortality: a retrospective observational cohort study. Neurol Res 2012; 34: 518-521.
9. Molshatzki N, Orion D, Tsabari R, et al: Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc Dis 2011; 31: 271-277.
10. Ni L, Lü J, Hou LB, et al: Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke 2007; 38: 3287-3288.
11. Hoke M, Amighi J, Mlekusch W, et al: Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke 2010; 41: 674-679.
12. Xiao D, Liu H, Zhang H, Luo Y: Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke. J Neurol 2012; 259: 2053-2059.
13. Kothari RU, Brott T, Broderick JP, et al: The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27: 1304-1305.
14. Brosius FC 3rd, Hostetter TH, Kelepouris E, et al: Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American heart association kidney and cardiovascular disease council; the councils on high blood pressure research, cardiovascular disease in the young, and epidemiology and prevention; and the quality of care and outcomes research interdisciplinary working group: developed in collaboration with the national kidney foundation. Circulation 2006; 114: 1083-1087.
15. Levey AS, Coresh J, Balk E, et al: National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
16. Menon V, Sarnak MJ: The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination. Am J Kidney Dis 2005; 45: 223-232.
17. Yahalom G, Schwartz R, Schwammenthal Y, et al: Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009; 40: 1296-1303.
18. Ovbiagele B, Bath PM, Cotton D, Sha N, Diener HC: Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation. Stroke 2013; 44: 3223-3225.
19. Wang X, Wang Y, Wang C, et al: Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China national stroke registry. Age Ageing 2014; 43: 839-845.
20. Hao Z, Wu B, Lin S, et al: Association between renal function and clinical outcome in patients with acute stroke. Eur Neurol 2010; 63: 237-242.
21. Coll E, Botey A, Alvarez L, et al: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000; 36: 29-34.
22. Berger PB, Best PJ, Topol EJ, et al: The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do tirofiban and Reo-Pro give similar efficacy outcome (TARGET) trial. Am Heart J 2005; 149: 869-875.
23. Hirsh J, Anand SS, Halperin JL, Fuster V: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American heart association. Circulation 2001; 103: 2994-3018.
24. Ovbiagele B, Wing JJ, Menon RS, et al: Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage. Stroke 2013; 44: 2409-2413.
25. Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW: The relation between chronic kidney disease and cerebral microbleeds: difference between patients with and without diabetes. Int J Stroke 2012; 7: 551-557.